Effects of zinc supplementation on clinical outcomes in patients receiving radiotherapy for head and neck cancers: a double-blinded randomized study.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  2007-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.IJROBP.2007.06.073PMID 17980503
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Zinc and immunity.

  2009cited by this paper
• Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study.

  2006cited by this paper
• Zinc induced apoptosis in HEP‐2 cancer cells: The role of oxidative stress and mitochondria

  2005cited by this paper
• Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study.

  2004cited by this paper
• Prophylaxis of oral mucositis in irradiated head-and-neck cancer patients: a proposed classification scheme of interventions and meta-analysis of randomized controlled trials.

  2001cited by this paper
• Induction of apoptosis and necrosis by zinc in human thyroid cancer cell lines.

  2001cited by this paper
• Effects of bovine prostate powder on zinc, glucose, and insulin metabolism in old patients with non-insulin-dependent diabetes mellitus.

  1998cited by this paper
• Nutritional and zinc status of head and neck cancer patients: an interpretive review.

  1998cited by this paper
• Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma.

  1997cited by this paper
• Decreased expression of CD73 (ecto-5'-nucleotidase) in the CD8+ subset is associated with zinc deficiency in human patients.

  1997cited by this paper
• Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans.

  1997cited by this paper
• Zinc deficiency affects cell cycle and deoxythymidine kinase gene expression in HUT-78 cells.

  1996cited by this paper
• Zinc and immunity.

  1994cited by this paper
• Biochemistry of Zinc

  1993cited by this paper
• Role of zinc in post-injury wound healing.

  1992cited by this paper
• Ecto 5' nucleotidase (5'NT) as a sensitive indicator of human zinc deficiency.

  1991cited by this paper
• Serum thymulin in human zinc deficiency.

  1988cited by this paper
• Interrelationships between zinc and immune function.

  1986cited by this paper
• Benzydamine hydrochloride in prevention and management of pain in oral mucositis associated with radiation therapy.

  1986cited by this paper
• Nutritional Status-a Prognostic Indicator in Head and Neck Cancer

  1985cited by this paper
• The value of the prognostic nutritional index in the management of patients with advanced carcinoma of the head and neck.

  1984cited by this paper
• The therapeutic implications of some recent research on trauma.

  1984cited by this paper
• Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency.

  1983cited by this paper
• Serum zinc, serum copper, and the Cu/Zn ratio in patients with epidermoid cancers of the head and neck

  1980cited by this paper
• Penetration of 65Zn through the skin of rats.

  1979cited by this paper
• Zinc therapy of depressed cellular immunity in acrodermatitis enteropathica. Its correction.

  1979cited by this paper
• Zinc and copper levels in whole blood and plasma from patients with squamous cell carcinomas of head and neck

  1979cited by this paper
• Circulating thymic hormone levels in zinc deficiency.

  1979cited by this paper

• Redox Balance in Cancer in the Context of Tumor Prevention and Treatment

  2025cites this paper
• Zinc availability in the tumor microenvironment dictates anti-PD1 response in CDKN2ALow tumors via increased macrophage phagocytosis

  2025cites this paper
• Metabolic interplays between the tumour and the host shape the tumour macroenvironment

  2025cites this paper
• Dietary interventions in cancer: a systematic review of all randomized controlled trials

  2024cites this paper
• Comparative evaluation of serum zinc level in head and neck cancer patients before and after radiation therapy

  2023cites this paper
• Comparison of effects of dexmedetomidine and amifostine against X-ray radiation-induced parotid damage

  2022cites this paper
• Zinc as a complementary treatment for cancer patients: a systematic review

  2021cites this paper
• Complementary and Alternative Medicine in Radiotherapy: A Comprehensive Review.

  2020cites this paper
• Can zinc supplementation widen the gap between control and complications in head and neck cancer patients treated with concurrent chemo-radiotherapy

  2019cites this paper
• Frequency of Low Serum Zinc Levels in Patients with Cerebral Infarction

  2016cites this paper
• Effects of Zinc Sulfate Supplementation on Cell-Mediated Immune Response in Head and Neck Cancer Patients Treated with Radiation Therapy

  2015cites this paper
• Anticancer activity of pyrithione zinc in oral cancer cells identified in small molecule screens and xenograft model: Implications for oral cancer therapy

  2015cites this paper
• Zinc supplements for preventing otitis media.

  2014cites this paper
• Komplementärer Einsatz von Antioxidanzien und Mikronährstoffen in der Onkologie

  2013cites this paper
• The Protective Role of Zinc in Cancer: A Potential Chemopreventive Agent

  2012cites this paper
• Nutrition chez le patient adulte atteint de cancer : compléments alimentaires antioxydants pendant et au décours du traitement des cancers

  2012cites this paper
• Hypoxia in Head and Neck Cancers: Clinical Relevance and Treatment

  2011cites this paper
• Clinical Significance of Serum Zinc Levels in Cerebral Ischemia

  2011cites this paper
• Tumor hypoxia is an important mechanism of radioresistance in hypofractionated radiotherapy and must be considered in the treatment planning process.

  2011cites this paper
• Effect of zinc supplementation on N-nitrosomethylbenzylamine-induced forestomach tumor development and progression in tumor suppressor-deficient mouse strains.

  2011cites this paper
• Zinc supplementation suppresses 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis.

  2011cites this paper
• The Zinc Ionophore PCI-5002 Radiosensitizes Non-small Cell Lung Cancer Cells by Enhancing Autophagic Cell Death

  2011cites this paper
• Effect of zinc supplementation on N -nitrosomethylbenzylamine-induced forestomach tumor development and progression in tumor suppressor-deficient mouse strains

  2011cites this paper
• Zinc in innate and adaptive tumor immunity

  2010cites this paper
• Zinc deficiency activates S100A8 inflammation in the absence of COX-2 and promotes murine oral-esophageal tumor progression

  2010cites this paper
• Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: Follow‐up of a double‐blind randomized study with subgroup analysis

  2009cites this paper